LAMOTRIGINE ER 300 MG TABLET

lamotrigine extended release
$1.2330per EA

Strength

300 mg/1

Manufacturer

Endo USA Inc.

NDC

49884060511

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA201791

On Market Since

1/18/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

-3.3%

3M

-11.0%

6M

-5.7%

1Y

-18.2%

3Y

-48.5%

5Y

-70.8%

All

-92.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.